CBD 101:

Is CBD Legal in Arkansas? Arkansas Cannabis, Hemp, and CBD Laws (2026)

mm
Add MyCannabis.com to your preferred sources on Google

Compliant hemp-derived CBD can be sold in Arkansas, but the current law requires more than a label showing 0.3% THC or less. Act 934 regulates consumable hemp products through Arkansas Tobacco Control, sets a minimum age of 21 and narrowly defines the products that remain permitted.

The product’s formulation and sales category matter as much as its hemp origin. This guide explains those distinctions, the state’s intoxicating-hemp ban and the federal changes approaching in late 2026.

Which CBD Products Can Qualify?

Act 934 defines lawful consumable hemp through specific categories, not a checklist in which any single favorable fact makes a product legal:

  • Qualifying cosmetics meeting the statutory THC level.
  • Products with applicable FDA generally-recognized-as-safe status, used consistently with that recognition.
  • Qualifying full-spectrum or specified cannabinoid products, including CBD products, with no more than 1 mg total THC per container and a CBD-to-THC ratio greater than 15:1.

The last category includes additional composition conditions. These products must not be marketed for intoxication. A low THC percentage alone is insufficient, and absence of living seeds does not establish legality.

The Act broadly defines intoxicating hemp but excludes compliant consumable hemp and regulated medical marijuana. Its restrictions therefore should not be simplified to either “all CBD is unaffected” or “every trace of THC is banned.”

Arkansas CBD and Hemp Laws Explained

Arkansas built its CBD framework in stages. The Arkansas Industrial Hemp Act, passed in 2017, first authorized hemp cultivation through a state research program, ending decades of blanket prohibition. The commercial Arkansas Hemp Program, run by the Arkansas Department of Agriculture, now operates under the Arkansas Hemp Production Act of 2021 and the 2018 federal Farm Bill, and 2022 was the first year of commercial hemp production in the state. The program licenses residents to grow, process, or handle hemp and its derivatives — including the hemp that becomes CBD oil.

The 2018 Farm Bill is the foundation underneath all of this. It excluded qualifying hemp from federal controlled-substance treatment while preserving FDA authority over consumer products. It did not approve every CBD food or supplement for sale. Arkansas then aligned its own law with the federal standard: in 2019, House Bill 1518 removed hemp-derived CBD from the state’s list of controlled substances, opening the door to a retail CBD market that includes products the FDA has not formally endorsed.

Cultivation permission does not replace consumer-product authorization. Arkansas Tobacco Control now oversees the consumable-hemp framework, while the medical marijuana program remains separate.

Arkansas’s Ban on Delta-8 and Intoxicating Hemp

Arkansas has banned delta-8, delta-10, and other intoxicating hemp-derived cannabinoids. Lawmakers passed Act 629 in 2023 to outlaw the production, sale, and transport of those products, but a hemp-industry coalition led by Bio Gen LLC sued, and a federal district judge blocked enforcement that September on the grounds the law was too vague and conflicted with the Farm Bill.

That hold did not last. On June 24, 2025, the U.S. Court of Appeals for the Eighth Circuit reversed the injunction and cleared the state to enforce the ban, finding that the 2018 Farm Bill does not prevent a state from restricting intoxicating hemp products within its borders. Enforcement began that July, and the Arkansas Department of Finance and Administration moved quickly, taking enforcement action against prohibited hemp products.

Lawmakers then strengthened the framework with Act 934 of 2025, which updated and expanded the 2023 law and handed the Arkansas Tobacco Control Board authority to regulate consumable hemp products. After the state won a final judgment in the underlying lawsuit, Attorney General Tim Griffin certified the act on April 22, 2026, activating the expanded regulatory framework. The earlier enforcement of Act 629 should not be confused with the later certification of Act 934. You can see how Arkansas compares with the rest of the country in our guide to where delta-8 is legal. CBD products must meet the current consumable-hemp definition and applicable sales requirements; merely staying below 0.3% THC does not make them unaffected.

Federal Hemp Changes Have Two Dates

The 2025 federal amendments narrow the hemp definition, including a finished-product exclusion above 0.4 mg per container of combined THC, THCA and specified similar-effect cannabinoids. That is a container threshold, not a serving limit or a cap on CBD.

Section 2019 of the September 2026 extension delays most changes until December 11, 2026. Exclusions for cannabinoids the cannabis plant cannot naturally produce remain scheduled for November 12.

Some state-compliant full-spectrum CBD can be affected. Arkansas’s 1 mg category does not create an exemption from the lower federal threshold. Manufacturing exclusions also require separate attention, and an online seller’s willingness to ship is not proof of compliance.

FDA Food and Supplement Rules Still Apply

The FDA prohibits adding CBD to food in interstate commerce and marketing CBD as a dietary supplement. State consumable-hemp authorization does not remove those restrictions. Hemp seed ingredients with recognized food uses are not the same as CBD additives.

CBD Possession and Medical Cannabis

There is no separate adult quantity allowance that makes an otherwise prohibited CBD product lawful. Evaluate the actual formulation, the consumer’s age and the applicable product category. A container-limit rule cannot be avoided by describing the purchase as personal use.

Arkansas’s medical marijuana program provides a separate route for qualifying patients. Cannabis possession outside an applicable exemption can carry criminal penalties; the hemp label alone does not establish an exemption.

Can Doctors Prescribe CBD Oil in Arkansas?

No. Arkansas doctors cannot prescribe over-the-counter CBD, and you do not need a prescription to buy it. Hemp-derived CBD products are sold as wellness items, not approved medicines, but purchases must still satisfy age and product requirements. As with medical marijuana, a physician may discuss or recommend CBD, but cannot write a prescription for the products on store shelves.

The one exception is Epidiolex, a CBD-based drug the FDA has approved for certain rare seizure disorders; that medication is available by prescription, while general CBD products are not. Outside of that, CBD is widely marketed for sleep, stress, and discomfort, and researchers continue to study cannabinoids for conditions ranging from epilepsy to chronic pain. Apart from Epidiolex, though, the FDA has not approved CBD to treat, cure, or prevent any disease.

Consumable Hemp Purchases Are Restricted to Adults 21 and Older

Act 934 defines a minor as someone under 21 and prohibits providing consumable hemp products to minors. Its restrictions also reach a minor’s purchase, use and possession, subject to specified enforcement and employment exceptions.

This is a legal requirement, not merely a retailer preference. Keep the state medical program and prescription-medicine pathways separate from ordinary consumable hemp sales.

Permits and the Product Directory

Arkansas Tobacco Control administers permits for consumable-hemp manufacturers, wholesalers and retailers. Its application and compliance forms include product-directory certification and retail warning notices.

Check the business’s authorization and applicable product-directory listing. A tobacco permit, laboratory report or hemp-growing license should not be assumed to substitute for all consumable-hemp requirements. Online sales are included in the regulatory framework.

Evaluating CBD Sellers

Check the seller’s permit and the exact product’s eligibility before comparing price or convenience. Review a batch-matched laboratory report, ingredients, total THC per container and the CBD-to-THC ratio where applicable. A favorable customer review cannot establish legal compliance or medical effectiveness.

A laboratory test describes the sampled batch at the time of testing; it does not guarantee current freshness or storage conditions. Follow expiry and storage instructions, and consult our guide to CBD oil stability for background.

Recommended U.S. CBD suppliers

Top CBD brands that ship in the USA

2026 picks
Brand
Best fit
Link
CBDfx
Best overall, broad product range
Foria
Botanical wellness and topicals
Vena CBD
THC-free daily precision
CBDfx
1
Best overall

Wide catalog with CBD gummies, tinctures, capsules, topicals, and functional formulas.

  • Organically grown, non-GMO hemp
  • CO2 extraction and third-party testing
  • 60-day satisfaction guarantee
View CBDfx
Foria
2
Botanical wellness

Plant-focused formulas for topical relief, daily wellness, and botanical support.

  • USDA-certified organic hemp
  • Clean botanical ingredient focus
  • Strong topical and intimate wellness lineup
View Foria
Vena CBD
3
THC-free precision

Standardized CBD products for readers who want clear dosing without THC exposure.

  • 0.0% THC product emphasis
  • Gummies, tinctures, and capsules
  • Independent lab testing
View Vena CBD

Affiliate Disclosure: We may earn a commission from links in this section at no cost to you. This section is informational only and is not medical or legal advice. Learn More.

Arkansas CBD FAQ

Does less than 0.3% THC make a CBD product legal?

No. Current rules also depend on product category, formulation, permits and other sales requirements.

Is delta-8 legal?

Arkansas prohibits intoxicating hemp products under its current framework, including chemically converted THC products covered by the law.

Do I need a medical card for compliant hemp CBD?

A medical card is not required for an otherwise lawful adult consumable-hemp purchase. Medical marijuana and prescription CBD medicine follow separate rules.

What federal dates matter?

November 12 and December 11, 2026 apply to different provisions. Businesses should assess both the manufacturing exclusions and the finished-container threshold.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.